Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report Achillion Pharmaceuticals, Inc. (ACHN): Free Stock Analysis Report Halozyme Therapeutics, Inc. (HALO): Free Stock Analysis Report Alexion Pharmaceuticals, Inc. (ALXN): Get Free Report Akari Therapeutics ...
28 different firms, including Barclays and BMO Capital, currently also have a Buy rating on the stock. Based on 17 analyst ratings, the analyst consensus is Strong Buy with an average price target of $159.25, reflecting a -28.3% downside. Starting in April 2018, ALXN received 12 Buy ratings...